Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme

This prospective study was aimed to test changes in hemostasis in patients with GBM, occurring at baseline (before surgery, time 0, T0) and 2 (T2), 24 (T24), and 48-hour (T48) after surgery. We enrolled consecutive patients subjected to GBM resection (GBR group; N = 60), laparoscopic colon cancer re...

Full description

Bibliographic Details
Main Authors: Santiago R. Leal-Noval, Manuel Casado, Cancela Palomares, José L. Narros, José L. García-Garmendia, Ginés Escolar, Diego X. Cuenca, Klaus Görlinger
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2023.2216802
_version_ 1797684107757486080
author Santiago R. Leal-Noval
Manuel Casado
Cancela Palomares
José L. Narros
José L. García-Garmendia
Ginés Escolar
Diego X. Cuenca
Klaus Görlinger
author_facet Santiago R. Leal-Noval
Manuel Casado
Cancela Palomares
José L. Narros
José L. García-Garmendia
Ginés Escolar
Diego X. Cuenca
Klaus Görlinger
author_sort Santiago R. Leal-Noval
collection DOAJ
description This prospective study was aimed to test changes in hemostasis in patients with GBM, occurring at baseline (before surgery, time 0, T0) and 2 (T2), 24 (T24), and 48-hour (T48) after surgery. We enrolled consecutive patients subjected to GBM resection (GBR group; N = 60), laparoscopic colon cancer resection (comparative CCR group; N = 40), and healthy blood donors (HBD group; N = 40). We performed 1. conventional coagulation tests 2. ROTEM (rotational thromboelastometry) parameters and 3. platelet function tests, including PFA-200 closure time when stimulated by collagen/epinephrine (COL-EPI) and ROTEM platelet, using three different activators (arachnoid acid in ARATEM, adenosine diphosphate in ADPTEM, and thrombin receptor-activating peptide-6 in TRAPTEM). Variables associated with unfavorable 1-year clinical outcome were investigated, too. We observed in GBR patients that platelet aggregometry, as assessed by ROTEM platelet parameters, was significantly impaired along with a shortened closure time. These changes were evident from T0 to T48. A decreased area under the aggregation curve in TRAPTEM was associated with improved survival (adjusted odd ratio (95% CI), 1.03 (1.01–1.06)). This study suggests that patients with GBM presented a decreased platelet aggregation from before surgery and thorough the postoperative period. Decreased platelet aggregation improved clinical outcome.
first_indexed 2024-03-12T00:25:44Z
format Article
id doaj.art-f8887d63eff748d99003714446a507e7
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:25:44Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-f8887d63eff748d99003714446a507e72023-09-15T10:38:12ZengTaylor & Francis GroupPlatelets0953-71041369-16352023-12-0134110.1080/09537104.2023.22168022216802Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiformeSantiago R. Leal-Noval0Manuel Casado1Cancela Palomares2José L. Narros3José L. García-Garmendia4Ginés Escolar5Diego X. Cuenca6Klaus Görlinger7University Hospital ‘Virgen del Rocío’University Hospital ‘Virgen del Rocío’University Hospital ‘Virgen del Rocío’University Hospital ‘Virgen del Rocío’Master on Design and Statistics for Health Sciences, Hospital ‘San Juan de Dios del Aljarafe’University Hospital ClinicUniversity Hospital ‘Virgen del Rocío’University Hospital EssenThis prospective study was aimed to test changes in hemostasis in patients with GBM, occurring at baseline (before surgery, time 0, T0) and 2 (T2), 24 (T24), and 48-hour (T48) after surgery. We enrolled consecutive patients subjected to GBM resection (GBR group; N = 60), laparoscopic colon cancer resection (comparative CCR group; N = 40), and healthy blood donors (HBD group; N = 40). We performed 1. conventional coagulation tests 2. ROTEM (rotational thromboelastometry) parameters and 3. platelet function tests, including PFA-200 closure time when stimulated by collagen/epinephrine (COL-EPI) and ROTEM platelet, using three different activators (arachnoid acid in ARATEM, adenosine diphosphate in ADPTEM, and thrombin receptor-activating peptide-6 in TRAPTEM). Variables associated with unfavorable 1-year clinical outcome were investigated, too. We observed in GBR patients that platelet aggregometry, as assessed by ROTEM platelet parameters, was significantly impaired along with a shortened closure time. These changes were evident from T0 to T48. A decreased area under the aggregation curve in TRAPTEM was associated with improved survival (adjusted odd ratio (95% CI), 1.03 (1.01–1.06)). This study suggests that patients with GBM presented a decreased platelet aggregation from before surgery and thorough the postoperative period. Decreased platelet aggregation improved clinical outcome.http://dx.doi.org/10.1080/09537104.2023.2216802aggregometry, coagulation, glioblastoma, hemostasis, platelet, rotem
spellingShingle Santiago R. Leal-Noval
Manuel Casado
Cancela Palomares
José L. Narros
José L. García-Garmendia
Ginés Escolar
Diego X. Cuenca
Klaus Görlinger
Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
Platelets
aggregometry, coagulation, glioblastoma, hemostasis, platelet, rotem
title Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
title_full Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
title_fullStr Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
title_full_unstemmed Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
title_short Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
title_sort prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme
topic aggregometry, coagulation, glioblastoma, hemostasis, platelet, rotem
url http://dx.doi.org/10.1080/09537104.2023.2216802
work_keys_str_mv AT santiagorlealnoval prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT manuelcasado prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT cancelapalomares prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT joselnarros prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT joselgarciagarmendia prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT ginesescolar prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT diegoxcuenca prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme
AT klausgorlinger prospectiveassessmentofplateletfunctioninpatientsundergoingelectiveresectionofglioblastomamultiforme